Electromed, Inc. (ELMD)
NYSEAMERICAN: ELMD · IEX Real-Time Price · USD
15.77
-0.41 (-2.53%)
At close: Apr 26, 2024, 4:00 PM
15.89
+0.12 (0.76%)
After-hours: Apr 26, 2024, 4:00 PM EDT
Electromed Market Cap
Electromed has a market cap or net worth of $135.70 million as of April 26, 2024. Its market cap has increased by 53.17% in one year.
Market Cap
135.70M
Enterprise Value
131.12M
1-Year Change
53.17%
Ranking
Category
Stock Price
$15.77
Market Cap Chart
Since August 13, 2010, Electromed's market cap has increased from $32.60M to $135.70M, an increase of 316.27%. That is a compound annual growth rate of 10.96%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 139.20M | -3.33% |
Apr 24, 2024 | 144.00M | 2.13% |
Apr 23, 2024 | 141.00M | 4.21% |
Apr 22, 2024 | 135.30M | 8.41% |
Apr 19, 2024 | 124.80M | 4.00% |
Apr 18, 2024 | 120.00M | -1.32% |
Apr 17, 2024 | 121.60M | -1.86% |
Apr 16, 2024 | 123.90M | -1.74% |
Apr 15, 2024 | 126.10M | 0.80% |
Apr 12, 2024 | 125.10M | -1.42% |
Apr 11, 2024 | 126.90M | -0.39% |
Apr 10, 2024 | 127.40M | -1.09% |
Apr 9, 2024 | 128.80M | -2.35% |
Apr 8, 2024 | 131.90M | -0.30% |
Apr 5, 2024 | 132.30M | -1.05% |
Apr 4, 2024 | 133.70M | 0.68% |
Apr 3, 2024 | 132.80M | -0.15% |
Apr 2, 2024 | 133.00M | -4.73% |
Apr 1, 2024 | 139.60M | 0.43% |
Mar 28, 2024 | 139.00M | -1.56% |
Mar 27, 2024 | 141.20M | 0.93% |
Mar 26, 2024 | 139.90M | -1.34% |
Mar 25, 2024 | 141.80M | -4.38% |
Mar 22, 2024 | 148.30M | -0.07% |
Mar 21, 2024 | 148.40M | -2.05% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Butterfly Network | 148.49M |
Biodesix | 144.33M |
ClearPoint Neuro | 143.24M |
Scilex Holding Company | 143.06M |
Tevogen Bio Holdings | 139.92M |
Syros Pharmaceuticals | 136.31M |
Augmedix | 135.98M |
Repare Therapeutics | 132.87M |